Zobrazeno 1 - 10
of 1 338
pro vyhledávání: '"Cystic fibrosis related diabetes"'
Autor:
Ane Bayona, Edurne Lecumberri Pascual, Saioa Vicente, Luis Maíz, Ana Morales, Adelaida Lamas, Cristina Sánchez Rodríguez, Rosa Yelmo, María Martín-Frías, Victoria Martínez Vaello, Enrique Blitz Castro, Lía Nattero-Chávez
Publikováno v:
Diabetology, Vol 5, Iss 6, Pp 554-565 (2024)
Introduction: Limited studies have explored the impact of cystic fibrosis (CF) transmembrane conductance regulator (CFTR) modulators on glucose tolerance and insulin secretion in patients with CF, yielding varied results. This study aims to assess al
Externí odkaz:
https://doaj.org/article/2c1aef925b2b4568a2f266f096d482de
Autor:
Nadezhda V. Liabina, Pavel A. Tikhonovskiy, Olga I. Simonova, Serafima G. Bystrova, Ina Sokolov, Irina V. Shirokova
Publikováno v:
Consilium Medicum, Vol 26, Iss 4, Pp 246-250 (2024)
Background. Forms of glucose metabolism disorders are one of the key processes in the course of cystic fibrosis (CF) and can be variable, starting with impaired glucose tolerance (IGT) and ending with cystic fibrosis-related diabetes (CFRD), which is
Externí odkaz:
https://doaj.org/article/a88e8253c61e48b7a2d76cb776bbdcfe
Autor:
Marta Bassi, Daniele Franzone, Francesca Dufour, Giordano Spacco, Federico Cresta, Giuseppe d’Annunzio, Giacomo Tantari, Maria Grazia Calevo, Carlo Castellani, Nicola Minuto, Rosaria Casciaro
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Background and aimsCystic fibrosis related diabetes (CFRD) is correlated with worsening of nutritional status and greater deterioration of lung function. The role of new technologies for the treatment of CFRD is little explored. The aim of the study
Externí odkaz:
https://doaj.org/article/59ba0506af3243d3afb8590729ca3939
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 36, Iss , Pp 100344- (2024)
Cystic fibrosis (CF) has been traditionally viewed as a disease that affects White individuals. However, CF occurs among all races, ethnicities, and geographic ancestries. The disorder results from mutations in the CF transmembrane conductance regula
Externí odkaz:
https://doaj.org/article/6f79d26b2d0b4cf2bc19719ecce8f474
Autor:
Saba Sheikh, Darko Stefanovski, Marissa J. Kilberg, Denis Hadjiliadis, Ronald C. Rubenstein, Michael R. Rickels, Andrea Kelly
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Insulin secretion within 30 minutes of nutrient ingestion is reduced in people with cystic fibrosis (PwCF) and pancreatic insufficiency and declines with worsening glucose tolerance. The glucose potentiated arginine (GPA) test is validated for quanti
Externí odkaz:
https://doaj.org/article/9eeb2aa56d794eaba42d9d8a793761d6
Autor:
Kevin J. Scully, Laura Brenner, Kimberly Martin, Melanie Ruazol, Gregory S. Sawicki, Ahmet Uluer, Isabel Neuringer, Lael M. Yonker, Leonard Sicilian, Melissa S. Putman
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
IntroductionsCystic fibrosis-related diabetes (CFRD) is associated with pulmonary decline, compromised nutritional status, and earlier mortality. Onset is often insidious, so screening for early detection of glycemic abnormalities is important. Conti
Externí odkaz:
https://doaj.org/article/3ca9ccea3c3744a4ab80d058eb77dea9
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Cystic fibrosis (CF) is a multi-organ disease caused by loss-of-function mutations in CFTR (which encodes the CF transmembrane conductance regulator ion channel). Cystic fibrosis related diabetes (CFRD) occurs in 40-50% of adults with CF and is assoc
Externí odkaz:
https://doaj.org/article/0b938453eae94ecda480ced02c4cc63f
Autor:
Montemari AL, Manco M, Fiocchi AG, Bartoli M, Facchiano F, Tabolacci C, Scatigna M, Ciciriello F, Alghisi F, Montemitro E, Carsetti R, Lucidi V, Fiscarelli EV
Publikováno v:
Journal of Inflammation Research, Vol Volume 15, Pp 5677-5685 (2022)
Anna Lisa Montemari,1 Melania Manco,2 Alessandro Giovanni Fiocchi,3 Manuela Bartoli,4 Francesco Facchiano,5 Claudio Tabolacci,5 Maria Scatigna,6 Fabiana Ciciriello,3 Federico Alghisi,3 Enza Montemitro,3 Rita Carsetti,7 Vincenzina Lucidi,3 Ersilia Vit
Externí odkaz:
https://doaj.org/article/eb1949f7a2b143618a91e4797b795b50
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 33, Iss , Pp 100323- (2023)
Background: Cystic fibrosis related diabetes (CFRD) is associated with insulin-remediable pulmonary decline, so early detection is critical. Continuous glucose monitors (CGM) have shown promise in screening but are not recommended by clinical practic
Externí odkaz:
https://doaj.org/article/057c3fb08e1a44c28ba603d78192ca3e
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 33, Iss , Pp 100320- (2023)
Aims: Combined CFTR modulator therapies have dramatically altered pulmonary outcomes in patients with cystic fibrosis (CF). Their impact on glucose metabolism requires further investigations. This study aims to evaluate insulin requirements after ini
Externí odkaz:
https://doaj.org/article/01c8f81f4e5540b9970499549a43428d